- This event has passed.
Let’s get interactive – with this webchat on MDS via UCL Hospital
When: Wedn 6th July 2016 – 12noon
Where: Online – via this UCLH webpage
Consultant haematologist Dr Beth Payne who specialises in treating patients with myelodysplastic syndromes and bone marrow failure.
Our expert is consultant haematologist Dr Beth Payne who specialises in treating patients with myelodysplastic syndromes and bone marrow failure. She is also a Senior Clinical Researcher funded by the Wellcome Trust and The Leuka John Goldman Fellowship for future Science and runs a research laboratory studying the mechanisms of disease in bone marrow failure and myelodysplastic syndromes and is also working to develop novel therapeutics.
The conversation will focus on managing the condition from diagnosis to treatment. Questions related to all aspects of myelodysplastic syndromes and related conditions are welcome.
How to take part:
To join in the conversation, simply visit the UCLH page at 12:00 on Wednesday 6 July 2016.
Questions in advance: submit them to email@example.com
Dr Payne will try to answer your question on the day.
We plan to submit the following questions:
- Which MDS trials do you think are most promising at the moment?
- What MDS trials is UCLH currently running in MDS?
- Are you using lenalidomide for MDS patients who are not del 5q (on a off-label basis)? Can you tell us about your experience so far?
- Can you tell us more about the UCLH ambulatory stem cell transplant setup ?
How does it work – how does it differ from the experience in the normal hospital setting?
UCLH opened an ambulatory stem cell transplant “hotel” for patients who are having their treatment there – in isolation – it is called the Cotton Rooms.
Read more here:
You can also ask Dr Payne about treatment at UCLH.